<DOC>
	<DOCNO>NCT00198172</DOCNO>
	<brief_summary>This study propose evaluate combination cisplatin plus epirubicin patient refractory germ cell tumor amendable cure surgery standard platinum salvage chemotherapy . This regimen use eligible patient progression ECOG Study E39897 .</brief_summary>
	<brief_title>Phase II Study Cisplatin Plus Epirubicin Salvage Chemo Refractory Germ Cell Tumors</brief_title>
	<detailed_description>To determine feasibility toxicity combine epirubicin fix cisplatin ; determine partial complete response rate duration remission ; determine toxicity ; ascertain potential great 12 month continuous disease-free survival , therefore , potential curability .</detailed_description>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Epirubicin</mesh_term>
	<criteria>histologic serologic proof metastatic germ cell neoplasm ( gonadal extragonadal primary ) w/ disease amenable cure either surgery chemotherapy . Pts w/ seminoma &amp; nonseminoma eligible , woman w/ ovarian germ cell tumor . Must fail initial cisplatin combination therapy administer w/ curative intent . In addition , pt fail demonstrated progressive disease follow administration least one `` salvage '' regimen advance germ cell neoplasms unless primary mediastinal nonseminomatous germ cell tumor , consider late relapse ( &gt; 2 yr since become complete response ) . Pts must adequate system function ( WBC &gt; /= 4,000 &amp; plts &gt; /=100,000 ; SGOT &lt; /=4x normal ; bilirubin &lt; /=2.0 ; serum crt &lt; /=2.5 ) obtain &lt; /= 4 wks prior entry . ECOG performance status 0,1 , 2 . Pts must least 3 week post major surgery , radiotherapy , chemotherapy , recover toxicity . Active , unresolved infection and/or receive concurrent treatment w/ parenteral antibiotic . *Eligible antibiotic discontinue least 7 day . Pregnant lactate Progression w/in 4 wks lst course cisplatin combination chemotherapy .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Germ Cell Tumor</keyword>
	<keyword>Refractory Germ Cell Tumors</keyword>
	<keyword>Cisplatin plus Epirubicin Salvage Chemotherapy</keyword>
</DOC>